Log In
Print this Print this

idraparinux (SR34006)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSynthetic long-acting pentasaccharide that indirectly inhibits Factor Xa
Molecular Target Factor Xa
Mechanism of ActionFactor Xa inhibitor
Therapeutic ModalityMacromolecule: Polysaccharide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today